Ultragenyx Pharmaceu (RARE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2000 | 12-1999 | |
| Sales | 453,664 | 382,470 |
| Cost of Goods | 166,421 | 137,416 |
| Gross Profit | 287,243 | 245,054 |
| Operating Expenses | 246,358 | 218,511 |
| Operating Income | 41,306 | 26,959 |
| Interest Expense | 4,159 | 3,866 |
| Other Income | -2,407 | -1,609 |
| Pre-tax Income | 34,740 | 21,484 |
| Income Tax | 11,480 | 7,060 |
| Net Income Continuous | 23,260 | 14,424 |
| Net Income Discontinuous | N/A | -1,587 |
| Net Income | $23,260 | $12,837 |
| EBITDA(a) | $41,306 | $26,959 |